scholarly journals New developments in cognitive behavioral therapy as the first-line treatment of insomnia

Author(s):  
Allison Siebern ◽  
Manber
2021 ◽  
Vol 12 ◽  
pp. 215013272110140
Author(s):  
Michael L. Perlis ◽  
Wilfred R. Pigeon ◽  
Michael A. Grandner ◽  
Todd M. Bishop ◽  
Dieter Riemann ◽  
...  

“Why treat insomnia?” This question grows out of the perspective that insomnia is a symptom that should only receive targeted treatment when temporary relief is needed or until more comprehensive gains may be achieved with therapy for the parent or precipitating medical or psychiatric disorders. This perspective, however, is untenable given recent data regarding the prevalence, course, consequences, and costs of insomnia. Further, the emerging data that the treatment of insomnia may promote better medical and mental health (alone or in combination with other therapies) strongly suggests that the question is no longer “why treat insomnia,” but rather “when isn’t insomnia treatment indicated?” This perspective was recently catalyzed with the American College of Physicians’ recommendation that chronic insomnia should be treated and that the first line treatment should be cognitive-behavioral therapy for insomnia (CBT-I).


2021 ◽  
Vol 3 (1) ◽  

This paper discusses cognitive-behavioral therapy and its implications in treating veterans with PTSD. This paper reviews current literature and research on the adaption of CBT for varying cultural factors and the efficiency of CBT in the treatment of PTSD. Research shows that CBT is effective in the treatment of PTSD and continues to be a first-line treatment intervention. CBT has been adapted for varying diagnosis and symptomology and continues to evolve. Future implications and research are needed on how varying elements of CBT are effective with veterans.


CNS Spectrums ◽  
2003 ◽  
Vol 8 (5) ◽  
pp. 356-362 ◽  
Author(s):  
Nadine Recker Rayburn ◽  
Michael W. Otto

ABSTRACTThis article provides an overview of cognitive-behavioral therapy (CBT) for panic disorder. CBT is currently considered a first-line treatment for panic disorder. It offers benefit after short-term intervention, typically consisting of 12–15 sessions conducted in either an individual or a group format. The treatment focuses on the elimination of the patterns that underlie and perpetuate the disorder. Through CBT, patients learn about the nature of the disorder and acquire a set of strategies that counter the fears of panic attacks themselves, and break the recurring cycle of anticipatory anxiety, panic, and agoraphobic avoidance. The collaborative format of treatment, and a focus on elimination of core fears may be factors in enhancing longer-term outcome. In this article, we review the efficacy of CBT as a first-line treatment, a strategy for medication nonresponders, a replacement strategy for patients who wish to discontinue pharmacotherapy, and a potential preventive strategy for at-risk individuals. We also discuss some of the complex issues involved with combination-treatment strategies.


Author(s):  
Catherine C. Loomis

Our knowledge of sleep disorders has grown dramatically in recent years, and sleep disorders are increasingly being recognized by the medical community and the public. Cognitive-behavioral therapy for insomnia has extensive research to support its effectiveness and is now seen as the first-line treatment for insomnia. Beyond insomnia, there are promising approaches to address psychological and behavioral aspects of many sleep disorders. This chapter describes the field of behavioral sleep medicine and outlines the author’s experience in developing a private practice devoted to sleep disorders. It offers advice for those who may be interested in practicing in this area and addresses business aspects of this niche practice. Resources are provided for readers who want to further their knowledge in this area.


Author(s):  
Wilfred R. Pigeon ◽  
Henry J. Orff

The neurobiology of insomnia is intertwined with that of sleep and wakefulness. Conceptual models of insomnia are being refined to accommodate sleep-wake research and insomnia-specific research, including animal models. Neurobiological abnormalities associated with insomnia include homeostatic dysregulation; circadian abnormalities; and somatic, cognitive, and cortical hyperarousal. The role of hyperarousal in particular has been supported by evidence generated from a variety of psychophysiological measures and neuroimaging techniques. Insomnia is also associated with alterations in neuroendocrine and neuroimmune function. For the treatment of insomnia, both pharmacological and nonpharmacological approaches are efficacious with cognitive-behavioral therapy for insomnia considered the first-line treatment and with development of novel agents ongoing.


2017 ◽  
Vol 2 (1) ◽  
pp. 020117
Author(s):  
Hanna Burda

Generalized anxiety disorder - is a common disease, which is quite difficult diagnosed and treated. Cognitive-behavioral therapy is indicated to patients with GAD as a first-line method. This article provides an overview of the principles, advantages and evidence of the effectiveness of this type of therapy. Although cognitive behavioral therapy has advantage over other types of therapy for GAD, this issue requires further research, because there are problems such as a high percentage of patients interrupting therapy and relatively low percentage of clinically meaningful improvement.


Sign in / Sign up

Export Citation Format

Share Document